Prescribe and resolve—with superior efficacy
Natroba™ is the only FDA-approved prescription head lice treatment that demonstrated 88% and 102% greater efficacy than Nix® (permethrin 1%) in two head-to-head, phase III clinical trials (see Studies 1 and 2 below).1
Dr. Christopher Belcher: President, Infectious Disease of Indiana and Director of Pediatric Infectious Diseases, Peyton Manning Children’s Hospital.
No nit combing required
In two Phase III trials, a small Natroba™ nit combing arm was included for descriptive purposes. These data provide further evidence that nit combing with Natroba™ is not required.1
Nix® is a registered trademark of Prestige Brands, Inc.
- Data on file.
- DOW AgroSciences 2001.